Lantheus Holdings, Inc. Patent Applications Rejected
7 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-11-07: Application 18503465; Invention PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF; Applicant Molecular Insight Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-07-26: Application 17873516; Invention Heterodimers of Glutamic Acid; Applicant Molecular Insight Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2021-04-23: Application 17238535; Invention HETERODIMERS OF GLUTAMIC ACID; Applicant Molecular Insight Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-11-16: Application 17099440; Invention HETERODIMERS OF GLUTAMIC ACID; Applicant Molecular Insight Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-11-07 | 18503465 | PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF | Molecular Insight Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20240174782A1 | Jason Moss Machinani Rao | United States United States | ROGERS, JAMES WILLIAM |
| 2022-07-26 | 17873516 | Heterodimers of Glutamic Acid | Molecular Insight Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | John W. Babich Craig N. Zimmerman Kevin P. Maresca | United States United States United States | ||
| 2021-04-23 | 17238535 | HETERODIMERS OF GLUTAMIC ACID | Molecular Insight Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210246103A1 | John W. Babich Craig N. Zimmerman Kevin P. Maresca | United States United States United States | RODRIGUEZ, RAYNA B |
| 2020-11-16 | 17099440 | HETERODIMERS OF GLUTAMIC ACID | Molecular Insight Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210070696A1 | John W. Babich Craig N. Zimmerman Kevin P. Maresca | United States United States United States | RODRIGUEZ, RAYNA B |
| 2020-05-08 | 16870288 | HETERODIMERS OF GLUTAMIC ACID | Molecular Insight Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210070695A1 | John W. Babich Craig N. Zimmerman Kevin P. Maresca | United States United States United States | RODRIGUEZ, RAYNA B |
| 2015-10-23 | 14921898 | PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF | Molecular Insight Pharmaceuticals Inc. | Abandoned -- After Examiner's Answer or Board of Appeals Decision | US20160115267A1 | Jason Moss Machinani Rao | United States United States | ROGERS, JAMES WILLIAM |
| 2014-10-17 | 14517760 | METHODS OF USING SPECT/ | Molecular Insight Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20150110716A1 | Thomas ARMOR | United States | CHIN, JENNIFER L |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |